The Analyst Landscape: 9 Takes On Tenet Healthcare
Portfolio Pulse from Benzinga Insights
Nine analysts have recently updated their ratings on Tenet Healthcare (NYSE:THC), showing a mix of bullish and somewhat bullish perspectives with no bearish views. The average 12-month price target for THC has been raised to $108.0, up 13.48% from the previous target of $95.17. Analyst actions include maintaining, raising, and announcing ratings with price targets ranging from $100.00 to $122.00. Tenet Healthcare, a Dallas-based healthcare services organization, has shown solid revenue growth and profitability but faces challenges in debt management.
March 27, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tenet Healthcare's stock may see positive short-term movement due to bullish analyst ratings and raised price targets, despite concerns over debt management.
The increase in the average price target and predominantly bullish ratings from analysts suggest a positive outlook for THC's stock. However, the company's high debt-to-equity ratio is a concern that might temper investor enthusiasm. The short-term impact is likely positive due to the recent upgrades and positive revenue growth and profitability metrics.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100